U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C11H16O
Molecular Weight 164.2441
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FENIPENTOL

SMILES

CCCCC(O)C1=CC=CC=C1

InChI

InChIKey=OVGORFFCBUIFIA-UHFFFAOYSA-N
InChI=1S/C11H16O/c1-2-3-9-11(12)10-7-5-4-6-8-10/h4-8,11-12H,2-3,9H2,1H3

HIDE SMILES / InChI

Description

Fenipentol is a choleretic agent indicated for the treatment of chronic liver disease and bile duct disease. The drug is sold without prescription.

Approval Year

Unknown
149,124

Targets

Primary TargetPharmacologyConditionPotency
Secretion of bile
1
Activator
1,447

Conditions

ConditionModalityTargetsHighest PhaseProduct
Chronic liver disease
2
 Primary
Approved
8,583
FEBICHOL
Bile duct disease
1
 Primary
Approved
8,583
FEBICHOL

PubMed

Patents

04268455
1
JP2003335623A
5
JP2004002219A
5
JP2005082490A
6
JP2009242321A
1
JPH01221320A
1
JPH1143471A
1

Sample Use Guides

In Vivo Use Guide
Standard dosage for adults and youths over 15 years of age is 2 capsules (each capsule of contains 100 mg of active ingredient fenipentol) three times a day (always immediately before meals).
Route of Administration: Oral
In Vitro Use Guide
Unknown
ACTIVE MOIETY
Structure of FENIPENTOL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966